What is Amphastar Pharmaceuticals's change in AP?

Amphastar Pharmaceuticals (AMPH) reported change in AP of $9.6M in Q1 2026.

How has Amphastar Pharmaceuticals's change in AP changed year-over-year?

Amphastar Pharmaceuticals's change in AP decreased by 45.5% year-over-year, from $17.61M to $9.6M.

What is the long-term trend for Amphastar Pharmaceuticals's change in AP?

Over 2 years (2022 to 2025), Amphastar Pharmaceuticals's change in AP has grown at a 148.9% compound annual growth rate (CAGR), from -$736K to -$4.56M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Amphastar Pharmaceuticals AMPH Change in AP

Change in AP at other companies

PfizerPFE

-$117.25M+54.2%

Halozyme TherapeuticsHALO

-$24.92M-370%

ViatrisVTRS

$32.7M-67.8%

Opko HealthOPK

$3.5M-69.5%

AptarGroupATR

$36.42M+9.3%

ARS Pharmaceuticals, Inc.SPRY

$10.32M+147%

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$927.72M-19.9%

Enterprise value$1.44B-11.3%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's change in AP?: Amphastar Pharmaceuticals (AMPH) reported change in AP of $9.6M in Q1 2026.
How has Amphastar Pharmaceuticals's change in AP changed year-over-year?: Amphastar Pharmaceuticals's change in AP decreased by 45.5% year-over-year, from $17.61M to $9.6M.
What is the long-term trend for Amphastar Pharmaceuticals's change in AP?: Over 2 years (2022 to 2025), Amphastar Pharmaceuticals's change in AP has grown at a 148.9% compound annual growth rate (CAGR), from -$736K to -$4.56M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.